Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk test

ConclusionsIncreased CIPN symptoms are associated with increased mobility deficits. The 6MWT demonstrates promising utility as a mobility assessment in a CIPN cohort.Implications for Cancer SurvivorsThe impact of the progression of CIPN on mobility deficits in survivors emphasizes the need for effective interventions to treat and prevent CIPN.

http://link.springer.com/10.1007/s11764-019-00769-7

Source: Journal of Cancer Survivorship - June 5, 2019 Category: Cancer & Oncology Source Type: research